Thales Introduces CipherTrust Intelligent Protection to Automate Security for Sensitive Data
10.11.2021 11:00:00 EET | Business Wire | Press release
Building on the success of the CipherTrust Data Security Platform, Thales has released CipherTrust Intelligent Protection, a new solution that further simplifies operational complexity and strengthens data security efforts with automated processes that discover, protect and control sensitive data anywhere. Faced with overwhelming data growth, organisations can use CipherTrust Intelligent Protection to safeguard all sensitive information without the added cost and complexity of traditional data protection products and services. Once the sensitive data has been discovered and classified based on vulnerability and other risk profiles, the new solution automatically protects at-risk data with encryption and robust access controls.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211110005012/en/
©Thales
CipherTrust Intelligent Protection is a solution configuration within the Thales CipherTrust Data Security Platform that works together with CipherTrust Manager, CipherTrust Data Discovery and Classification, and CipherTrust Transparent Encryption –an all-in-one solution that delivers a unified approach. CipherTrust Intelligent Protection addresses the evolving challenges of regulatory compliance by facilitating accelerated time to compliance with automatic data protection controls. It also offers easy-to-use, pre-programmed tools to quickly and effectively secure unstructured sensitive data on-premises and in the cloud.
Reducing complexity in data protection with integrated automation
As organisations contend with expanding datasets, permanent work-from-home or hybrid office schemes, and the increased use of multi-cloud services, lack of visibility places their sensitive data at risk. Thales’s 2021 Data Threat Report found that the use of cloud-based infrastructure exposes new risks as an organisation’s data footprint expands and raises concerns about operational complexity. Less than a quarter (24%) of respondents said they have complete knowledge of where their data is stored. Configurable policies with built-in templates to rapidly discover and classify unstructured sensitive data can be used to protect data on-premises and in the cloud.
“Cloud computing services and data security requirements will only grow more complex as organisations work to keep pace with new and evolving work environments,” said Todd Moore, VP Encryption Products at Thales. “Increased operational complexity demands simplified security procedures, and CipherTrust Intelligent Protection makes it significantly easier for companies to safeguard data proactively based on known vulnerabilities and data privacy regulations, which reduces overall business risk. Intelligent Protection provides the automation so customers can confidently take data security measures into their own hands with an all-in-one solution.”
Accelerating time-to-compliance
Today’s businesses and organisations must remain in compliance with a broad range of regulations and mandates, including GDPR, CCPA, HIPAA, and PCI DSS. Data privacy laws and regulations are never static – new ones appear regularly and existing ones often get enhanced, making it difficult for you to keep pace. An integrated and automated solution helps eliminate blind spots and human error, making a considerable difference in complying with various regulations.
"This all-in-one solution combines the best of the Ground Labs' data discovery technology with Thales’ CipherTrust Data Security Platform to give organizations the power to automatically discover, classify and keep sensitive data secure, whether it's on-premises or in the cloud," said Stephen Cavey, co-founder and chief evangelist of Ground Labs. “Our partnership with Thales underscores our common mission to protect our customers, regardless of where they store their data - and through this collaboration, we can better meet the data security needs of customers today and in the future."
“Managing risk is becoming increasingly burdensome for IT leaders not only because of the volume and sophistication of cyber-attacks but also due to the operational complexity of managing disparate security products and services,” said Frank Dickson, Program Vice President, Security & Trust, IDC. “Truly integrated platforms that automate the discovery, classification and protection of sensitive data can help organisations reduce both hard costs and risks associated with stitching together multivendor solutions while addressing and mitigating soft costs by simplifying data security operations and compliance.”
Uncover and Close Security Gaps
Finding a way to rapidly identify data compliance gaps and potential security risks is of paramount importance. Using the high performance and accurate discovery engine is an extremely useful way to find data subject to regulations that organizations may not realize even exists. CipherTrust Data Discovery and Classification provides risk-based guidance on what specific data to encrypt. Linking this discovery process to CipherTrust Transparent Encryption provides organizations with a fast track to automatically uncover and close security gaps.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005012/en/
Contact information
PRESS
Thales, Media Relations
Security
Constance Arnoux
+33 (0)6 44 12 16 35
Constance.arnoux@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 10:00:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced deep tech executive with more than 25 years delivering products across multiple industries from startups to Fortune 500 companies, will advance IQM's technology strategy and drive its implementation into systems and products. De Vega, meanwhile, will be responsible for ensuring scientific feasibility and system-level
Teijin Receives Approval for Additional Indications of XEOMIN ® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 10:00:00 EEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 09:00:00 EEST | Press release
Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L
Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 20:07:00 EEST | Press release
Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Helio Strap Pro represents the next evolution of Amazfit's Hybrid Training System, extending performance tracking beyond heart rate to help athletes bett
HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 18:30:00 EEST | Press release
HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
